Patent · US Active

Recombinant viral vectors

US9802986B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2015
Grant dateOct 31, 2017
Priority date
Expiry dateDec 17, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/162
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.